ÌìÃÀ´«Ã½

ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
ÌìÃÀ´«Ã½ Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ÌìÃÀ´«Ã½ Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ÌìÃÀ´«Ã½ Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 3330

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • ÌìÃÀ´«Ã½ J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

Cancer therapy design based on pathway logic

18th Biotechnology Congress

Aniruddha Datta

Texas A & M University, USA

ScientificTracks Abstracts: J Biotechnol Biomater

DOI:

Abstract
Cancer encompasses various diseases associated with loss of cell-cycle control, leading to uncontrolled cell proliferation and/ or reduced apoptosis. Cancer is usually caused by malfunction(s) in the cellular signaling pathways. Malfunctions occur in different ways and at different locations in a pathway. Consequently, therapy design should first identify the location and type of malfunction and then arrive at a suitable drug combination. We consider the growth factor (GF) signaling pathways, widely studied in the context of cancer. Interactions between different pathway components are modeled using Boolean logic gates. All possible single malfunctions in the resulting circuit are enumerated and responses of the different malfunctioning circuits to a �test� input are used to group the malfunctions into classes. Effects of different drugs, targeting different parts of the Boolean circuit, are taken into account in deciding drug efficacy, thereby mapping each malfunction to an appropriate set of drugs
Biography

Aniruddha Datta received his PhD degree from the University of Southern California in 1991. In August 1991, he joined the Department of Electrical and Computer Engineering at Texas A&M University where he is currently the J. W. Runyon, Jr. ’35 Professor II. His areas of interest include adaptive control, robust control, PID control and genomic signal processing

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top